@EntheonBiomedical
Daily Mushroom + Entheon Biomedical Mental Health Town Hall Replay
Daily Mushroom + Entheon Biomedical Mental Health Town Hall Replay
Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.
Amanda Siebert of The Dales Report Interviews CEO, Timothy Ko and Chief Science Officer, Dr. Andrew Hegle
Amanda Siebert of The Dales Report Interviews CEO, Timothy Ko and Chief Science Officer, Dr. Andrew Hegle
Entheon Biomedical CEO Timothy Ko & CSO Dr. Andrew Hegle on how DMT could potentially be used as a treatment for substance use disorder and more.
Latest News Release - EBRX-101 Ethics Approval
Latest News Release - EBRX-101 Ethics Approval
Our Website
Our Website
Contact Us
Contact Us
Find us on Wealthsimple!
Find us on Wealthsimple!
Smart investing products and dedicated financial planning and advice services to build long-term wealth. Low-fee managed investing, commission-free trading, and high-interest chequing and savings.
Psychedelic Medicines to Treat Addiction | BTV News
Psychedelic Medicines to Treat Addiction | BTV News
CEO, Timothy Ko explains why Entheon is focusing on DMT
CEO, Timothy Ko explains why Entheon is focusing on DMT
Facebook
Facebook
YouTube
YouTube
LinkedIn
LinkedIn
X
X
View on mobile